1. Goerres GW, Schmid DT, Gratz KW, et al. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2003;39:547–51.
2. Zanation AM, Sutton DK, Couch ME, et al. Use, accuracy, and implications for patient management of F-18 FDG PET/CT for head and neck tumors. Laryngoscope. 2005;115:1186–90.
3. Burri RJ, Rangaswamy B, Kostakoglu L, et al. Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2008;17:682–8.
4. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995;36:1747–57.
5. Myers LL, Wax MK, Nabi H, et al. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope. 1998;108:232–6.